Clinical Trial Update: Post Authorization Efficacy and Safety Study (PAES) to Confirm and Collect More Clinical Data of Buccalin® Tablets In the Prophylaxis of Recurrent Lower Respiratory Tract Infections (RLRTIs). [Phase 4]

View source ↗

Summary

Phase 4 post-authorization efficacy and safety study to confirm and collect more clinical data on Buccalin tablets for prophylaxis of recurrent lower respirator…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lower Respiratory Tract Infection
• Respiratory Tract Infection

Drugs mentioned

• Buccalin

Snippet

Sponsor: Laboratorio Farmaceutico SIT srl | Conditions: Respiratory Infection, Lower Respiratory Tract Infection (LRTI) | Phase 4 | Status: RECRUITING